China

Index
Globenewswire

WeRide Included in Hong Kong Stock Connect Program, Expanding Access to Mainland China Investors

Globenewswire

Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China

Globenewswire

HKTB Launches New Summer Promotion “Hong Kong Summer Fun” in Partnership with the Business Community to Attract Overnight Visitors and Boost Local Spending

Globenewswire

Sigenergy (HKEX: 6656.HK) Launches SigenAgent, a Goal-Based AI Energy Agent for Solar, Storage and EV Charging

Globenewswire

CGTN: 70 tahun hubungan Tiongkok-Afrika: Dari perjuangan bersama menuju impian bersama akan modernisasi

Globenewswire

SEIMC Launches Precision Gallbladder-Preserving Treatment to Safeguard Biliary Health

Globenewswire

CGTN: China-Africa ties at 70: From shared struggles to a common dream of modernization

Globenewswire

Sigenergy Unveils SigenAgent, the First All-Domain AI Agent for the Renewable Energy Industry

Globenewswire

FinVolution Launches 11th Global AI Competition: Teaching Voice AI When to Speak

Globenewswire

Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC

Globenewswire

CGTN: Mengutamakan rakyat: Prinsip utama dalam tata kelola Tiongkok

Globenewswire

CGTN: Putting people first: A guiding principle in China's governance

Globenewswire

C-Lingo: Transforming Chinese Language Learning in Vietnam with AI

Globenewswire

Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma

Globenewswire

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

Globenewswire

CGTN: Diplomasi di tingkat kepala negara menopang pertumbuhan kemitraan Tiongkok-Rusia

Globenewswire

WeRide Achieves Record Five Consecutive Wins at China Urban Intelligent Driving Competition

Globenewswire

CGTN: Head-of-state diplomacy anchors growing China-Russia partnership

Globenewswire

Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder

Globenewswire

Chengdu Origen and Vanotech Announce KHN921 Investigational New Drug application clearance by the US FDA for the treatment of hypertrophic cardiomyopathy (HCM) associated with MYBPC3 mutations

Globenewswire

CGTN: Mengapa dunia menyoroti KTT Tiongkok-AS yang akan datang?

Globenewswire

CGTN: Hari Ibu: Bagaimana para ibu heroik menginspirasi Xi Jinping

Globenewswire

CGTN: Why is the world watching the upcoming China-US summit?

Globenewswire

CGTN: Mother's Day: How heroic mothers inspire Xi Jinping

Globenewswire

Where Aesthetics Meets Technology — LEPAS Milan Public Days Define Elegant Mobility